About the authors
From the following article:
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
Rakesh K Jain, Dan G Duda, Jeffrey W Clark and Jay S Loeffler
BACK TO ARTICLERakesh K Jain
Rakesh K Jain is the Andrew Cook Professor of Tumor Biology at Harvard Medical School, and Director, Edwin L Steele Laboratory for Tumor Biology, Department of Radiation Oncology at Massachusetts General Hospital, Boston, MA, USA.
Dan G Duda
Dan G Duda is an Instructor at Harvard Medical School, and an Assistant Biologist in the Department of Radiation Oncology at Massachusetts General Hospital, Boston, MA, USA.
Jeffrey W Clark
Jeffrey W Clark is the Medical Director for Clinical Programs at the MGH Cancer Center, and Director for Clinical Trials Support at Dana-Farber/Partners Cancer Care, Boston, MA, USA.
Jay S Loeffler
Jay S Loeffler is the Herman & Joan Suit Professor of Radiation Oncology at Harvard Medical School and Chief, Department of Radiation Oncology at Massachusetts General Hospital, Boston, MA, USA.
